Viewing Study NCT00779935


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2025-12-25 @ 7:45 PM
Study NCT ID: NCT00779935
Status: COMPLETED
Last Update Posted: 2017-05-11
First Post: 2008-10-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module